Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
In Vivo (Athens, Greece)|March 1, 1990
Immunohistochemical evaluation of reverse transcriptase in breast carcinoma with polyclonal antibodies raised in rabbitC F Moyret, D J Bernard, J C Maurizis, et al.American Journal of Human Genetics|June 1, 1997
Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndromeT Lin, B M Orrison, A M Leahey, et al.International Journal of Oncology|September 15, 1998
Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinomaP G Rio, D Pernin, J O Bay, et al.Human Molecular Genetics|August 1, 2000
A mouse model of galactose-induced cataractsY Ai, Z Zheng, A O'Brien-Jenkins, et al.Endocrinology|June 30, 2000
Structure and expression of a membrane component of the inhibin receptor systemH Chong, S A Pangas, D J Bernard, et al.International Journal of Oncology|March 24, 1999
Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 geneD J Bernard-Gallon, M P De Latour, P G Rio, et al.Anticancer Research|August 11, 2001
Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosasD J Bernard-Gallon, M Peffault de Latour, C Hizel, et al.The Journal of Clinical Endocrinology and Metabolism|February 4, 2016
IGSF1 Deficiency: Lessons From an Extensive Case Series and Recommendations for Clinical ManagementS D Joustra, C A Heinen, N Schoenmakers, et al.Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.Cancer Genomics & Proteomics|January 9, 2009
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differencesN Chalabi, D J Bernard-Gallon, Y J Bignon, et al.Pageof 7